Skip to search formSkip to main contentSkip to account menu

Iothalamate sodium I125

Known as: Iothalamate Sodium I-125, Diatrizoate Sodium I 125, Benzoic Acid, 3-(acetylamino)diiodoiodo-(sup 125)I-5-((methylamino)carbonyl)-, Monosodium Salt 
The sodium salt form of iothalamate, an organic iodine compound, labeled with iodine I-125 and used as a radiopharmaceutical. Iothalamate sodium I… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Approximately 15% to 20% of patients with sickle cell disease have proteinuria. Proteinuria, particularly albuminuria, is the… 
Review
1991
Review
1991
Two hundred and seventy four patients with early carcinoma of the prostate were treated by ultrasound-guided transperineal I-125… 
1991
1991
The effects of both clot-bound and circulating plasminogen activator inhibitor-1 (PAI-1) on endogenous fibrinolysis were… 
1978
1978
A rapid, miniaturized chromatographic system was developed to determine the labeling efficiency of iodinated radio… 
1977
1977
The use of cuprous ion as a reducing agent for pertechnetate is described for the first time. The potential usefulness of a 99mTc… 
Highly Cited
1969
Highly Cited
1969
  • F. T. MaherW. Tauxe
  • 1969
  • Corpus ID: 41926254
Renal clearances of diatrizoate sodium I 125 or iothalamate sodium I 125 measure 90% to 100% of simultaneous classic clearances… 
1968
1968
ADDITIONAL COMPLEXITY has been added to the diagnosis of hydrocephalus by reports which suggest a “normal pressure” form of the…